Zocdoc
Health care technology company
Based in NY
🤖
AI Overview
With $1.9M in lobbying spend across 29 quarterly filings, Zocdoc is a significant lobbying presence. They deploy 13 individual lobbyists
$1.9M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
13
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $270K |
| 2019 | $320K |
| 2020 | $160K |
| 2021 | $100K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $300K |
| 2025 | $320K |
Lobbying Firms
INVARIANT LLC
What They Lobby For
- Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement, as well as discuss the limitations of the existing federal anti-kickback statute.
- Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement, as well as discuss the limitations of the existing federal anti-kickback statute; educate Members of Congress on technology-based price transparency.
- Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement, as well as discuss the limitations of the existing federal anti-kickback statute; discuss issues related to price transparency.
- Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to price transparency; highlight use of telehealth to reduce strain of COVID-19 patients on hospitals.
- Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to price transparency; support making COVID-19 telehealth waivers permanent.
- Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to price transparency; support making COVID-19 telehealth waivers permanent; discuss initiatives related to health disparities.
- Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to price transparency; support making COVID-19 telehealth waivers permanent; discuss initiatives related to health disparities; educate policymakers on company's scheduling capabilities.
- Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to price transparency.
- Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to price transparency; discuss issues related to the Anti-Kickback Statute.
- Educate Members of Congress about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to price transparency; discuss issues related to Anti-Kickback Statute; discuss issues related to information-blocking.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.